Who Actually Buys Care Homes in 2026? A Tour of the Buyer Universe

Who Actually Buys Care Homes in 2026? A Tour of the Buyer Universe

James Dixey — Founder and Managing Director    ·    9 min read    ·    James Dixey Limited

When a care home owner first calls us about selling, the second question after price is almost always some version of: who would actually buy this? The real buyer universe in 2026 is wider, more international and more polarised than most owners realise.

EXECUTIVE SUMMARY

•  The 2026 UK care home buyer universe is more polarised than most owners realise: US REITs (Welltower's c.£6.4bn+ acquisitions of Barchester, HC-One, Aria and Danforth — with Aria and Danforth now under Care UK management — and all four deals headed to a CMA Phase 2 review) at scale, and small/medium operator groups at the other end.

•  Christie & Co data (H1 2025) shows small and medium groups running 3–19 homes accounting for 32% of all deal volume; independent operators (1–2 homes) at 31%; first-time buyers at 17%, up from 4% two years earlier — a fourfold rise.

•  Portfolio shape determines who you should be talking to: large freehold portfolios to REITs, specialist platforms to PE, single homes and small groups (the typical James Dixey Limited mandate) to operator consolidators and the well-prepared first-time buyer pool.

•  The mistake to avoid is running one process for everyone. The diligence requirements, the timeline and the documentation are materially different for each buyer segment.

Considering selling your care home or care group?

Get a confidential, no-obligation valuation to understand what your business could be worth in this market and which segment of the buyer universe is most likely to pay best.

Get a valuation  →

The mental picture most owners start with is one or two buyer types — the local competitor down the road, or perhaps a private equity firm they have seen named in the trade press. The real buyer universe in 2026 is wider, more interesting and more international than that. It is also more polarised between very large institutional capital and genuinely small first-time buyers, with a thinner middle than there used to be.

Here is the tour we would give an owner thinking about a sale this year — and equally, what a buyer entering the market should know about who they are competing with.

The big money: US real estate capital

The single biggest story in UK care home M&A over the last eighteen months has been US-listed REITs arriving at unprecedented scale. Welltower completed acquisitions of Barchester (£5.2bn, October 2025), HC-One (£1.2bn, October 2025), and the operating and property companies of Aria Care (including Asprey, c.£615m) and Danforth Care (October 2025). On 18 December 2025, Welltower-owned Care UK took over management of the Aria and Danforth homes, making Care UK the UK's second-largest care provider with over 250 homes, 12,000+ beds and 15,000+ staff. In total the transactions cover 46 individual deals across more than 600 operational care homes. The CMA opened its investigation in January 2026, served initial enforcement orders on Welltower under section 72(2) of the Enterprise Act 2002 in February 2026, and on 7 May 2026 concluded its Phase 1 review — finding that each of the four acquisitions may give rise to a substantial lessening of competition in local markets. Absent acceptable undertakings, the deals are now headed for an in-depth Phase 2 investigation. The CMA has also signalled that it is examining whether wider "relevant merger situations" arise between Care UK and Aria Care, and between Apex and HC-One.

Separately, Omega Healthcare Investors took 45 Four Seasons homes in a 47-home portfolio sale by CBRE (£241.75m total, split with Gold Care taking the remaining two). CareTrust REIT (NYSE: CTRE) acquired Care REIT plc (formerly Impact Healthcare REIT) for approximately $840m, announced March 2025 and closed May 2025, marking CareTrust's entry into the UK market. The transaction added 132 care homes and approximately 7,500 beds across 14 operators. On the European side, the Aedifica/Cofinimmo combination — agreed June 2025, conditionally cleared by the Belgian Competition Authority on 21 January 2026 (subject to a €300m Belgian asset divestiture commitment) — saw Aedifica secure 79.57% of Cofinimmo shares in the Initial Acceptance Period that closed 2 March 2026. The combined entity has approximately €12bn of gross asset value, positioning it as the leading healthcare REIT in Europe and the #4 healthcare REIT globally.

What this group is buying is property exposure to a long-duration income stream. They are real estate investors first and care operators second, and they typically run an OpCo/PropCo structure with a sister operating company doing the day-to-day. For a seller with a high-quality freehold portfolio at scale, they are usually the highest-paying buyer in the market right now. For a single-asset owner, they are not the buyer — your home is too small to move the needle on a multi-billion-dollar balance sheet.

The operators: where most deals actually happen

Strip out the headline mega-deals and the picture changes completely. Christie & Co's transaction data for the first half of 2025 shows small and medium-sized groups (those running 3 to 19 homes) accounting for 32% of all care home deals — the most active buyer segment in the market — followed by independent operators with 1–2 homes at 31%. Large groups and corporates fell to just 20% of deals, down from 36% in 2023. The shift reflects where most actual deals are getting done in 2026: in the small- and mid-sized operator consolidation segment rather than at the headline end.

On the named-operator side, groups visibly active in the residential and dementia space through 2025 include Sandstone Care Group (now operating 13 homes across the North-West, Midlands and Wales), Lovett Care, Majesticare, Kara Healthcare in the Midlands, Hapus Care, Crown Care, B&M Care, and Exemplar Health Care in specialist nursing. In the learning disability and specialist services segment, Cygnet Social Care, Potens, Outcomes First Group and Salutem have been particularly visible. These are strategic buyers in the truest sense — they know how to run a home, they want operational fit, and they pay for it. The diligence process with an operator is sharper than with a financial buyer; they spot the underlying issues a generalist would miss. The trade-off is that they are usually the right buyer for an established business with sound fundamentals, not for a turnaround.

The middle: private equity, selectively

Mid-market private equity has been the most disciplined part of the buyer universe so far in 2026. The activity that has happened has been concentrated in specialist care — learning disabilities, complex needs, children's services — where unit economics are stronger and the regulatory barriers to entry are real. In our experience, PE has played a smaller role in elderly residential M&A in 2025 than in previous cycles while remaining active in specialist segments. BGF has been a consistent presence across the sector, with selective deployment into specialist learning disabilities and complex care platforms.

For a vanilla elderly residential portfolio, PE is generally not the buyer to chase in 2026. For a specialist platform with growth potential and a credible management team, it can still be the highest-value route — particularly for owners who want to roll some equity and stay involved through the next chapter.

The small end: more buyers than most owners expect

This is the part most owners underestimate. Christie & Co's Care Market Review 2025 puts small and medium-sized groups at 32% of all transactions in H1 2025, with independent operators at 31% — together accounting for nearly two-thirds of deal volume. First-time buyers — typically experienced care managers or sector executives stepping into ownership — accounted for 17% of deals in H1 2025, up from 11% in 2024 and just 4% in 2023. That fourfold increase in first-time-buyer activity over two years is one of the most consistent themes in the current market.

If you own a single home or a small group of three to five, this is where most of your real buyer interest will come from. The encouraging part is that this segment is genuinely competitive: debt is available for the right buyer through Shawbrook, Aldermore, HSBC's smaller-business division and a wider group of specialist lenders, and the supply of quality homes coming to market remains tighter than demand. The constraint is that these buyers move more slowly, are more sensitive to price, and need a process that gives them time to arrange funding and complete.

Family offices, HNW and the quiet money

A category that does not show up loudly in deal statistics but matters in any process is the patient-capital end of the market — UK and overseas family offices, high-net-worth individuals with a strategic interest in healthcare property, and an increasing flow of Asian and Middle Eastern capital looking for stable yield in a regulated market. Christie & Co specifically flagged the growing presence of European and overseas funds in its H2 2025 commentary. They rarely lead a competitive auction but they will turn up on a discreet, off-market sale process where speed and confidentiality matter more than headline price.

What this means if you are selling

The shape of your portfolio determines who you should be talking to. A portfolio of fifteen-plus homes with strong freeholds belongs in front of the REITs and the largest operating groups. A specialist platform with strong margins belongs in front of PE. A single home or small group — which is the typical James Dixey Limited mandate in the £3–15m enterprise value range — belongs in front of the operator consolidators and the well-prepared first-time buyer pool.

The mistake to avoid is running one process for everyone. The diligence requirements, the timeline and the documentation are materially different for each segment, and trying to please all of them slows the process and weakens your position with the buyer who would actually pay best.

What this means if you are buying

The competition you face depends entirely on the segment you target. Single-home and small-group buyers are competing with each other, plus the lower end of the operator consolidators. Larger platforms see global capital across the table. Specialist niches — dementia, learning disabilities, children's services — are the segments where well-prepared mid-market buyers can still find good value, because the fundamentals are strong and the institutional money is partly looking elsewhere. The market has also genuinely changed for first-time buyers: with their share of deal volume rising from 4% to 17% in two years, banks and specialist finance brokers are far more comfortable underwriting first-time-buyer transactions than they were even eighteen months ago, particularly for homes under £3m of enterprise value.

Related: What is my care home actually worth? A realistic guide to valuation.  (/guides/what-is-my-care-home-worth)

Selling a care home or care group?

We work with owner-managed care businesses across England, Scotland and Wales. The first conversation is always confidential and never costs anything — we can usually tell you within a day which segment of the buyer pool is the right starting point.

Get a valuation  →

SOURCES

[1] Welltower Inc. SEC Form 8-K Q3 2025 and earnings release (Barchester £5.2bn, HC-One £1.2bn, October 2025). CMA case page "Welltower / multiple care homes merger inquiries" (gov.uk/cma-cases): initial enforcement orders served 3-10 February 2026 under section 72(2) Enterprise Act 2002; Phase 1 review concluded 7 May 2026 with substantial-lessening-of-competition finding. CareTrust REIT / Care REIT plc transaction (closed 8 May 2025, $840.5m, 132 UK care homes c.7,500 beds).

[2] Care UK acquisitions of Aria and Danforth, December 2025. Coverage in LaingBuisson, Healthcare Property and care sector trade press.

[3] CareTrust REIT, Inc. announcements (March 2025 and May 2025 closing): $840m acquisition of Care REIT plc; 132 UK care homes; 7,500 beds; 14 operators; 20.2-year WALT.

[4] Omega Healthcare Investors / Four Seasons portfolio: 47-home freehold portfolio sold for £241.75m, completed 9 June 2025; Omega took 45 homes (leased to six operators including Gold Care, Harbour Healthcare, SpringCare, Belmont Healthcare and Jersey-based LV Care Group), Gold Care took 2 homes freehold; CBRE sell-side, Christie & Co buy-side. Press releases from Christie & Co, Omega and CBRE.

[5] Aedifica / Cofinimmo: announced June 2025; Belgian Competition Authority cleared January 2026 (with €300m Belgian asset divestment remedy); Aedifica secured 79.57% of Cofinimmo shares in acceptance period to 2 March 2026.

[6] Christie & Co Care Market Review 2025. H1 2025 transaction segmentation: 32% small/medium groups; 31% independents; 20% large groups (down from 36% in 2023); 17% first-time buyers (up from 11% in 2024 and 4% in 2023); 49% of deals were 20–39 bed homes.

James Dixey Limited — Specialist M&A for regulated, owner-managed businesses in Care, Education, Fire & Security and Other Regulated Services